RegeneRx Biopharmaceuticals (OTCMKTS:RGRX) Stock Price Up 4.3%

RegeneRx Biopharmaceuticals, Inc. (OTCMKTS:RGRX)’s stock price rose 4.3% on Thursday . The company traded as high as $0.20 and last traded at $0.18. Approximately 39,881 shares traded hands during mid-day trading, a decline of 18% from the average daily volume of 48,353 shares. The stock had previously closed at $0.18.

The business’s 50 day moving average price is $0.17 and its two-hundred day moving average price is $0.20.

About RegeneRx Biopharmaceuticals (OTCMKTS:RGRX)

RegeneRx Biopharmaceuticals, Inc focuses on the development of a novel therapeutic peptide, Thymosin beta 4, or Tß4, for tissue and organ protection, repair, and regeneration. Its products include RGN-259, RGN-352, and RGN-137. The company was founded by Allan L. Goldstein on May 13, 1982 and is headquartered in Rockville, MD.

See Also: What are the Different Types of Leveraged Buyouts?

Receive News & Ratings for RegeneRx Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RegeneRx Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.